drugset / Trial / NCT00963183
AZD5423 Single Ascending Dose Study
RandomizedParallel-groupTriple-blindBasic science
Summary
The aim of the study is to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD5423 following single ascending dose administrations in healthy male subjects.
Timeline
- Start
- 2009-08
- Primary completion
- 2009-11
- Completion
- 2009-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD5423 | Other / unclassified | 8.4 ug | Inhaled |
Indications
No indication recorded.